Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1905 of 5804
-
Can music therapy help autistic kids speak better?
Symptom relief CompletedThis research is a single-blind randomized controlled trial, where the investigators plan to recruit 40 children with autism, randomly divided into two groups. The music therapy intervention group will receive an hour of group music therapy in addition to traditional language the…
Phase: NA • Sponsor: National Taiwan University Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Glow-in-the-Dark dye could prevent surgical blunders
Diagnosis CompletedThis study evaluates the safety and efficacy of intravenous injection of IS-001 to aid in intraoperative ureter structure delineation.
Phase: PHASE3 • Sponsor: Intuitive Surgical • Aim: Diagnosis
Last updated Jun 27, 2026 08:11 UTC
-
Blood test may outshine scans for spotting hidden cancer after radiation
Knowledge-focused Recruiting nowSixty percent of newly diagnosed head and neck squamous cell carcinomas (HNSCCs) are at a locally advanced (LA) stage. Depending on tumor site, stage, and resectability, locoregional failure rates can range from 35% to 65%. The persistence of residual disease at the end of treatm…
Phase: NA • Sponsor: Centre Jean Perrin • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:38 UTC
-
Could a cheaper keytruda copy work for lung cancer?
Disease control OngoingThe goal of this clinical trial is to compare the amount of study drug in patients' blood to confirm that SB27 works in the same way as EU and US sourced Keytruda in early or locally advanced non-small cell lung cancer (NSCLC) patients who underwent surgery and adjuvant chemother…
Phase: PHASE1 • Sponsor: Samsung Bioepis Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a simple nasal spray replace antibiotics for sinusitis?
Symptom relief CompletedA two-week therapy of nitric oxide nasal spray (NONS) vs Placebo (saline nasal spray) initiated immediately after the onset of a new Recurrent Acute Rhinosinusitis (RARS) episode to assess the acceleration to clinical success (cured/much improved symptoms), lack of use of intrana…
Phase: PHASE2 • Sponsor: Sanotize Research and Development corp. • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Which surgery saves sight better after eye injection infection?
Disease control CompletedThis prospective comparative interventional study evaluated the anatomical and visual outcomes of phacovitrectomy versus pars plana vitrectomy (PPV) alone in patients with post-intravitreal injection endophthalmitis. Eligible patients underwent either combined phacovitrectomy or …
Phase: NA • Sponsor: Benha University • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Smartwatch may spot heart failure early
Diagnosis CompletedThe purpose of this study is to find out if there are any patterns in the way people's bodies react to physical activities and their voices when they have heart failure, a disease where the heart cannot function sufficiently. To do this, the investigators will use a smartwatch th…
Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Diagnosis
Last updated Jul 01, 2026 00:00 UTC
-
Feeding clock ticked: Time-Restricted nutrition may boost stroke outcomes
Disease control CompletedIn patients with severe stroke whose GCS score is ≤12 points or NIHSS score is ≥11 points, to evaluate whether time-restricted enteral nutrition can improve the incidence of poor 90-day prognosis (mRS ≥3 points) compared with continuous enteral nutrition.
Phase: NA • Sponsor: First Affiliated Hospital of Wannan Medical College • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
ALS drug trial halted: safety data sought from 54 patients
Disease control TerminatedThe primary purpose of this study is to evaluate the safety and tolerability of VRG50635 in participants with ALS.
Phase: PHASE1 • Sponsor: Verge Genomics • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Early, intense PT after stroke shows promise for better mobility
Symptom relief CompletedThe Department of Physical Therapy in conjunction with the Comprehensive Stroke Center at the Medical University of South Carolina (MUSC) seeks support for developing an evidence-based approach for the mobilization of patients within the first 24 hours of admission for an acute s…
Phase: NA • Sponsor: Medical University of South Carolina • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Clot-Sucking catheter may boost heart attack outcomes
Disease control OngoingAim of this single center randomized open label trial with blinded in-hospital outcomes assessment is designed with aim to compare manual thrombus aspiration followed by percutaneous coronary intervention (PCI) strategy with PCI alone.
Phase: NA • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 12:05 UTC
-
Can new tests predict who will develop active TB?
Knowledge-focused Recruiting nowIt has been estimated that 1.7 billion people have tuberculosis (TB) infection; yet current tests are unable to predict which people are at highest risk of developing TB disease, which can be life-threatening. THWART-TB is a prospective longitudinal cohort study of health workers…
Sponsor: Beth Israel Deaconess Medical Center • Aim: Knowledge-focused
Last updated Jul 10, 2026 00:00 UTC
-
Could customizing gut lengths in bypass surgery boost weight loss?
Disease control Recruiting nowThe investigators propose a randomized controlled trial comparing BP and roux limb lengths measuring 30 and 15% respectively of patient's total small bowel length versus current standard practice using fixed lengths. The findings would provide further insight into feasibility of …
Phase: NA • Sponsor: Salvador Navarrete • Aim: Disease control
Last updated Jun 27, 2026 11:03 UTC
-
New drug cocktail shows promise in rare stomach cancer trial
Disease control OngoingThe purpose of the study is to test the effects, both good and bad, of the research study drug Neratinib in combination with Trastuzumab, Pembrolizumab and FOLFOX chemotherapy. This study will also look at the safety of Neratinib in combination with Trastuzumab, Pembrolizumab and…
Phase: PHASE2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 13:07 UTC
-
Brain signal study could Fine-Tune Parkinson's therapy
Knowledge-focused Recruiting nowOur goal is to better understand how DBS modifies local neuronal activity and to pioneer device technologies that can record local DBS-evoked potentials (DLEPs) to guide therapy. Our vision is for a patient's unique electrophysiology to guide both electrode targeting during surge…
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:54 UTC
-
New hope for tough blood cancers: first human trial of GLB-001 begins
Disease control Recruiting nowStudy GLB-001-01 is a first-in-human (FIH), Phase 1, open-label, dose escalation and expansion clinical study of GLB-001 in participants with relapsed or refractory acute myeloid leukemia (R/R AML) or in participants with relapsed or refractory higher-risk myelodysplastic syndrom…
Phase: PHASE1 • Sponsor: GluBio Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Peer navigators aim to boost cancer trial enrollment for hispanic kids
Knowledge-focused Recruiting nowCOMPRENDO (ChildhOod Malignancy Peer Research NavigatiOn) is a multi-site randomized clinical trial (RCT) that uses a Hybrid Type 1 design, to test the effects of a clinical intervention on patient-level outcomes, while exploring multilevel implementation factors that can inform …
Phase: NA • Sponsor: University of California, San Diego • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC
-
Could a formula closer to breast milk boost baby development?
Knowledge-focused CompletedThis study aims to learn about a newly developed infant formula that adds two special ingredients found in breast milk (human milk oligosaccharides, HMOs) and improves other nutrients. We will compare the effects of this new formula, a currently available standard formula, and br…
Phase: NA • Sponsor: Heilongjiang Feihe Dairy Co. Ltd. • Aim: Knowledge-focused
Last updated Jul 23, 2026 00:00 UTC
-
New COPD drug itepekimab tested for Long-Term safety in 700 patients
Disease control OngoingThis is a parallel, double blind, Phase 3, 2-arm study that is designed to provide additional safety information, assess the durability of treatment response, and provide additional PK and immunogenicity assessments. The primary purpose of this study is to evaluate safety and to…
Phase: PHASE3 • Sponsor: Sanofi • Aim: Disease control
Last updated Jun 27, 2026 12:34 UTC
-
Iron pills before scoliosis surgery may cut transfusions and boost recovery
Disease control Recruiting nowThis study is a randomized controlled trial of preoperative oral iron supplementation, to identify whether iron deficiency is a modifiable risk factor for adverse surgical outcomes such as red blood cell transfusion and diminished postoperative cognitive and physical capacity in …
Phase: NA • Sponsor: Columbia University • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC